Paclitaxel resistance in breast cancer: Current challenges and recent advanced therapeutic strategies

This publication has 106 references indexed in Scilit:

• Cancer‐derived non‐coding RNAs endow tumor microenvironment with immunosuppressive properties
  WIREs RNA, 2023
• Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells
  Journal of Cancer Research and Clinical Oncology, 2023
• Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer
  Breast Cancer Research and Treatment, 2021
• Regulation of ATG and Autophagy Initiation
  2019
• Oxidative stress in apoptosis and cancer: an update
  Archives of Toxicology, 2012
• The role of Tau protein in resistance to paclitaxel
  Cancer Chemotherapy and Pharmacology, 2011
• Important aspects of Toll-like receptors, ligands and their signaling pathways
  Inflammation Research, 2010
• ABCB1 G1199A Polymorphism and Ovarian Cancer Response to Paclitaxel
  Journal of Pharmaceutical Sciences, 2008
• A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer
  Breast Cancer Research and Treatment, 2008
• NF‐κB as a potential molecular target for cancer therapy
  BioFactors, 2007